Antibiotic susceptibility patterns of Helicobacter pylori strains isolated from northeastern Mexico. 2002

E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
elvira_garza_gzz@yahoo.com

There are reports of increased antibiotic resistance rates in Helicobacter pylori strains around the world. The aim of this study was to determine the susceptibility patterns in H. pylori strains isolated in Monterrey, Mexico. We studied 62 strains isolated from the same number of symptomatic adult patients. Metronidazole (Mtz), clarithromycin (Cla), amoxicillin (Amx) and tetracycline (Tet) were tested by the E-test method. We observed that 37.1% of the strains were resistant to Mtz (MIC > or = 8 mg/L), and 8.1% to Cla (MIC > or = 8 mg/L), but we did not observe resistance to Amx (MIC > or = 2 mg/L) or Tet (MIC > or = 4 mg/L). In northeastern Mexico, the percentage of resistant strains was similar to that observed in developed countries. These results confirm that it is necessary to evaluate the susceptibility patterns of H. pylori strains by geographic area.

UI MeSH Term Description Entries
D008297 Male Males
D008795 Metronidazole A nitroimidazole used to treat AMEBIASIS; VAGINITIS; TRICHOMONAS INFECTIONS; GIARDIASIS; ANAEROBIC BACTERIA; and TREPONEMAL INFECTIONS. 2-Methyl-5-nitroimidazole-1-ethanol,Bayer 5360,Clont,Danizol,Flagyl,Gineflavir,Metric,MetroGel,Metrodzhil,Metrogyl,Metronidazole Hydrochloride,Metronidazole Monohydrochloride,Metronidazole Phosphate,Metronidazole Phosphoester,Satric,Trichazol,Trichopol,Trivazol,Vagilen,2 Methyl 5 nitroimidazole 1 ethanol
D008800 Mexico A country in NORTH AMERICA, bordering the Caribbean Sea and the Gulf of Mexico, between BELIZE and the UNITED STATES, and bordering the North Pacific Ocean, between Guatemala and the UNITED STATES.
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
August 2022, BMC microbiology,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
January 2017, Revista Argentina de microbiologia,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
February 2011, Helicobacter,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
January 2009, British journal of biomedical science,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
March 2018, Journal of global antimicrobial resistance,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
October 2004, Journal of clinical microbiology,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
October 2009, Revista medica de Chile,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
March 2016, Journal of infection in developing countries,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
January 2022, Journal of research in medical sciences : the official journal of Isfahan University of Medical Sciences,
E Garza-González, and G I Pérez-Pérez, and O Alanís-Aguilar, and R Tijerina-Menchaca, and H J Maldonado-Garza, and F J Bosques-Padilla
January 2020, Frontiers in microbiology,
Copied contents to your clipboard!